loading page

Evolution of Molecular Diagnosis in the Detection and Management of Viral Infectious Diseases in Nigeria
  • David Omotola Ojo,
  • Deborah Oluwaseun Shomuyiwa,
  • Don-Eliseo Lucero-Prisno
David Omotola Ojo
Nigerian Institute of Medical Research

Corresponding Author:[email protected]

Author Profile
Deborah Oluwaseun Shomuyiwa
University of Lagos Faculty of Pharmacy
Author Profile
Don-Eliseo Lucero-Prisno
London School of Hygiene & Tropical Medicine Department of Global Health and Development
Author Profile

Abstract

Molecular diagnostics have revolutionized viral disease diagnosis in clinical settings, offering rapidity, sensitivity, and specificity. Nigeria’s diverse burden of viral diseases, coupled with resource limitations and underreporting, underscores the critical need for efficient molecular diagnostics. The article traces the progressive trajectory of molecular diagnostics in Nigeria, including the establishment of Lassa virus detection, containment of the Ebola virus outbreak, and the pivotal role of the Nigeria Center for Disease Control (NCDC). It also highlights the impact of the COVID-19 pandemic on expanding molecular diagnostics infrastructure. Despite these advancements, challenges such as limited testing capacity, skilled personnel shortages, and inadequate funding persist. The article recommends measures to address these challenges, emphasizing the transformative potential of molecular diagnostics in viral surveillance and management. Overall, it underscores the importance of strategic planning and concerted efforts to enhance the utilization of molecular diagnostics in Nigeria’s healthcare system.
22 Sep 2023Submitted to Public Health Challenges
22 Sep 2023Submission Checks Completed
22 Sep 2023Assigned to Editor
29 Sep 2023Reviewer(s) Assigned
27 Oct 2023Review(s) Completed, Editorial Evaluation Pending
27 Oct 2023Editorial Decision: Revise Major
12 Feb 2024Review(s) Completed, Editorial Evaluation Pending
05 Jun 2024Submission Checks Completed
05 Jun 2024Assigned to Editor
05 Jun 2024Review(s) Completed, Editorial Evaluation Pending
09 Jun 2024Editorial Decision: Accept